Digital Health Startups

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

4 investors

MedCheck aggregates real-world clinical data from healthcare professionals in emerging markets through a cloud-based platform to enable data-driven decision-making. The company connects physicians, medical organizations, NGOs, and pharmaceutical firms to improve healthcare outcomes via electronic medical records, clinical study portals, and data analytics tools.

4 investors

Medfin helps patients in India access surgical care by connecting them with a network of doctors and hospitals, managing health insurance processing, and offering no-cost EMI financing for procedures. It focuses on modern, minimally invasive surgical procedures aimed at faster recovery and shorter hospital stays.

4 investors

Medfin provides an AI-powered analytics platform that automatically aggregates financial and operational data from dental practices to surface key metrics and actionable recommendations. The platform uses AI models to help practice owners optimize profitability, utilization, and operational efficiency through real-time alerts and performance benchmarking.

4 investors

MediShout develops an operational efficiency platform for hospitals, integrating supplier and helpdesk systems to reduce delays and improve patient care. The company serves NHS and private hospital groups across the UK.

4 investors

Medoma provides technology to support hospital-at-home care, enabling hospital-level treatment for high-acuity patients to be delivered in patients' homes. The company operates a digi-physical Hospital at Home care model in Sweden.

4 investors

MedRhythms develops digital therapeutics using music, sensors, and software combined with neuroscience to improve walking and mobility in patients with neurological conditions including stroke, multiple sclerosis, and Parkinson's disease.

4 investors

Mend develops clinically formulated nutrition products designed to support healing and recovery, marketed as "food as medicine." It partners with physicians to offer digital health coaching, remote patient monitoring, and nutritional formulas for patients across stages of recovery.

4 investors

Mental is a mobile app that helps men improve their mental well-being through action-oriented tools for managing stress, building discipline, and finding purpose. It offers evidence-based programs such as a Cold Shower Protocol and AI-based coaching developed with psychology PhDs.

4 investors

Mentavi Health provides clinician-reviewed online diagnostic evaluations that screen for up to 29 mental health conditions, including ADHD, anxiety, depression, and OCD, with results reviewed by licensed doctorate-level psychologists. It serves patients directly and partners with health systems, primary care providers, higher-education institutions, and employers across the United States.

4 investors

MicroTech Medical provides medical information services in China, with operational headquarters in Hangzhou and a principal place of business in Hong Kong.

4 investors

MIMOSA Diagnostics develops medical devices and technology to improve healthcare equity through diagnostic solutions. The company focuses on skin and wound healing diagnostics with a team led by experienced medical device engineers and healthcare professionals.

4 investors

An AI research organization that develops interface innovations and neural technologies, focusing on human-AI interaction breakthroughs including neural signal processing and thought decoding methods.

4 investors

MindRight Health provides culturally affirming mental health support through a community-based platform and network of peer supporters. The company serves individuals seeking accessible mental health care outside traditional systems.

4 investors

Minze Health develops solutions for diagnosing and managing lower urinary tract symptoms (LUTS), such as those caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB). The company targets the large population of adults affected by urinary conditions in the U.S. and EU.

4 investors

Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.

4 investors

Mojo is a mobile app offering expert-designed courses on sex, intimacy, and relationships, built on the biopsychosocial clinical model and delivered through video, audio, exercises, and AI-powered personalization. It serves individuals seeking private, evidence-based help with sexual and relationship challenges.

4 investors

Moneta Health provides virtual speech therapy focused on cognitive rehabilitation to treat cognitive impairment and dementia, aiming to improve patients' functional independence and quality of life. It serves patients and healthcare providers as part of post-diagnostic care.

4 investors

Mosanna is a pharmaceutical company developing a non-invasive nasal spray therapy for obstructive sleep apnea (OSA) that reactivates the body's natural airway reflex to keep the upper airway open during sleep. Its lead candidate, MOS-118, is a small molecule delivered before bedtime that stimulates upper airway dilator muscles to reduce apnea and hypopnea episodes.

4 investors

Death Clock is a preventive health platform powered by AI that identifies early markers of chronic disease before symptoms appear, helping users take action to prevent illness. The platform serves individuals interested in longevity and health optimization through early detection protocols.

4 investors

Munice is a sleep-tech startup that develops Renight, a mobile app offering science-based, personalized solutions to improve users' sleep. The company serves consumers globally and reports over 2 million users.

4 investors

Mural Health operates a patient-first participant management platform for clinical trials, addressing financial and logistical barriers that lead to participant dropout. The platform serves clinical research organizations and sponsors conducting trials globally.

4 investors

myBiometry develops electrochemical biosensor technology for non-invasive measurement of airway inflammation biomarkers, aimed at managing respiratory diseases such as asthma. The company builds diagnostic sensor devices and targets clinicians, patients, and the in vitro diagnostics market.

4 investors

Myndlift offers a neurotherapy platform that combines neuroscience with consumer technology to help people improve their brain health and cognitive well-being. The company serves tens of thousands of users seeking to optimize cognitive performance.

4 investors